MEDIA RELEASES 2024
-
Sep 12, 2024 • PDFType 1 Diabetes Program by RSSDI supported by Sanofi India’s Social Impact Initiative delivering positive outcomes (Bhubaneshwar)Sep 4, 2024 • PDFType 1 Diabetes Program by RSSDI supported by Sanofi India’s Social Impact Initiative delivering positive outcomes (Hyderabad)Jul 31, 2024 • PDFSanofi receives marketing authorization for Beyfortus® in India to protect infants & children against Respiratory Syncytial Virus (RSV)Jul 17, 2024 • PDFSanofi announces expansion of its Global Capability Centre in Hyderabad
MEDIA RELEASES 2023
-
Dec 19, 2023 • PDFSanofi India appoints Himanshu Bakshi as General Manager for its Consumer Healthcare businessDec 9, 2023 • PDFDiabetes awareness program in Goa’s schools sparking lifestyle changes to tackle rising Obesity trendSep 26, 2023 • PDFType 1 Diabetes Program by RSSDI supported by Sanofi’s Social Impact Initiative delivering positive outcomesAug 10, 2023 • PDFSanofi India Limited declares 12% growth in operating profits despite NLEM impact in Q2 (April- June), 2023Jul 11, 2023 • PDFDupixent® (dupilumab) is now approved in India for the treatment of adults with moderate-to-severe atopic dermatitisMay 10, 2023 • PDFSanofi India Limited to unlock value with dedicated pharma & consumer healthcare businessesFeb 27, 2023 • PDFSanofi reaffirms commitment to rare diseases in India
MEDIA RELEASES 2022
-
Jun 1, 2022 • PDFSanofi India appoints Preeti Futnani as General Manager, VaccinesApr 18, 2022 • PDFSanofi India appoints new Managing DirectorJan 13, 2022 • PDFSanofi India Ltd.’s Managing Director - Rajaram Narayanan to move on
MEDIA RELEASES 2021
MEDIA RELEASES 2020
-
Sep 29, 2020 • PDFSanofi Pasteur Launches Tetraxim®, the First Full-Dose DTaP Booster Vaccine in India for PreschoolersJun 30, 2020 • PDFSanofi India Launches ‘Allergy Free’Jun 6, 2020 • PDFSanofi Pasteur Launches VaxLine in IndiaMay 3, 2020 • PDF‘Lock Out’ pain through Combiflam® Plus’ newest digital campaign #LockdownWaaliLifeMar 19, 2020 • PDFSanofi India Press Statement for Ibuprofen
MEDIA RELEASES 2019
MEDIA RELEASES 2018
-
Oct 24, 2018 • PDFShantha Biotechnics’ Inactivated Polio Vaccine – ShanIPV™ prequalified by the World Health Organization (WHO)Oct 10, 2018 • PDFCombiflam® Range of Pain Relief Solutions introduces Pain Education Campaign in BiharAug 6, 2018 • PDFSanofi launches ‘once daily’ oral tablet ‘Aubagio®’, for treatment of Multiple Sclerosis in IndiaJul 23, 2023 • PDFSanofi Pasteur launches FluQuadri® - India’s first Four-Strain Influenza Vaccine for population above 3 years of ageJun 11, 2018 • PDFCombiflam® Range of Pain Relief Solutions launches Pain Education Campaign
MEDIA RELEASES 2017
-
Dec 15, 2017 • PDFSanofi India Limited appoints N. Rajaram as Managing DirectorOct 24, 2017 • PDFShantha Biotechnics’ Inactivated Polio Vaccine (IPV) completes delivery of 20 million doses to the Government of IndiaOct 11, 2018 • PDF23 young people with ‘type 1 diabetes’ scaled Maharashtra’s highest peak in India’s first T1D ChallengeSep 11, 2017 • PDFSanofi Launches ‘Combiflam® ICYHOT™’ Pain Relief Topical in India
MEDIA RELEASES 2016
MEDIA RELEASES 2015
MEDIA RELEASES 2014
-
Nov 10, 2014 • PDFShantha’s Pentavalent Pediatric Vaccine launched in IndiaOct 11, 2014 • PDFBhaichung Bhutia joins Sanofi India’s ‘Steps that Count’ World Arthritis Day initiative to raise awareness on knee osteoarthritisSep 30, 2014 • PDFApollo Hospitals and Sanofi announce collaboration to provide an integrated care program in India for people with diabetesAug 20, 2014 • PDFDiabetic Teen from Pune achieves unique featAug 6, 2014 • PDFSanofi partners with Emcure Pharmaceuticals for marketing and distribution of its oncology portfolio in IndiaJul 23, 2014 • PDFSchools lead fight against diabetes
MEDIA RELEASES 2013
MEDIA RELEASES 2012
MEDIA RELEASES 2011
MEDIA RELEASES 2010
MEDIA RELEASES 2008
-
Sep 20, 2008 • PDFOPPI Marketing Excellence Award (existing products category) for Lantus®Apr 24, 2008 • PDFSanofi-aventis launches SoloSTAR®
Contact the media team
Sanofi House,
L&T Gate no. 6,
Saki Vihar Road,
Powai. Mumbai - 400072
+91(0) 2228032112, 2446, 2169You are about to leave Sanofi.in
If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.
You are about to leave Sanofi.in
If you wish to continue to this external website, click Proceed.
You are about to leave Sanofi.in
You are about to visit another Sanofi website that is not governed by India regulatory.
Do you wish to proceed?